bullish

Miromatrix Medical

Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?

We believe that perfusion technology from Miromatrix differentiates from 3D bioprinting and genetically modified xenografts and has more advantages to develop high-quality bioengineered organs

Equity Capital Markets
277 Views, 08 Jul 2021 01:55
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Rising
Andrei Zakharov
Director of Equity Research, IPOs
Information Technology & EnergyEquitiesEquity Capital MarketsThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?
    08 Jul 2021
x